117 related articles for article (PubMed ID: 27855377)
1. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.
Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT
Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377
[TBL] [Abstract][Full Text] [Related]
2. Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection.
Lin RJ; Liao CL; Lin E; Lin YL
J Virol; 2004 Sep; 78(17):9285-94. PubMed ID: 15308723
[TBL] [Abstract][Full Text] [Related]
3. Activated Ras/MEK inhibits the antiviral response of alpha interferon by reducing STAT2 levels.
Christian SL; Collier TW; Zu D; Licursi M; Hough CM; Hirasawa K
J Virol; 2009 Jul; 83(13):6717-26. PubMed ID: 19386709
[TBL] [Abstract][Full Text] [Related]
4. Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction.
Parisien JP; Lau JF; Rodriguez JJ; Ulane CM; Horvath CM
J Virol; 2002 May; 76(9):4190-8. PubMed ID: 11932384
[TBL] [Abstract][Full Text] [Related]
5. Silencing SIRT1 promotes the anti-HBV action of IFN-α by regulating Pol expression and activating the JAK-STAT signaling pathway.
Tang Q; Meng C; Liu Y; Cheng Y; Liu Y; Long Y; Sun S; Feng F
Int Immunopharmacol; 2023 Nov; 124(Pt B):110939. PubMed ID: 37741128
[TBL] [Abstract][Full Text] [Related]
6. Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling.
Jia D; Rahbar R; Chan RW; Lee SM; Chan MC; Wang BX; Baker DP; Sun B; Peiris JS; Nicholls JM; Fish EN
PLoS One; 2010 Nov; 5(11):e13927. PubMed ID: 21085662
[TBL] [Abstract][Full Text] [Related]
7. HCV NS5A and IRF9 compete for CypA binding.
Bobardt M; Hopkins S; Baugh J; Chatterji U; Hernandez F; Hiscott J; Sluder A; Lin K; Gallay PA
J Hepatol; 2013 Jan; 58(1):16-23. PubMed ID: 22902549
[TBL] [Abstract][Full Text] [Related]
8. Conventional protein kinase C inhibition prevents alpha interferon-mediated hepatitis C virus replicon clearance by impairing STAT activation.
Fimia GM; Evangelisti C; Alonzi T; Romani M; Fratini F; Paonessa G; Ippolito G; Tripodi M; Piacentini M
J Virol; 2004 Dec; 78(23):12809-16. PubMed ID: 15542633
[TBL] [Abstract][Full Text] [Related]
9. Interferon alpha regulates MAPK and STAT1 pathways in human hepatoma cells.
Zhao LJ; Hua X; He SF; Ren H; Qi ZT
Virol J; 2011 Apr; 8():157. PubMed ID: 21466707
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway.
Chen DY; Khan N; Close BJ; Goel RK; Blum B; Tavares AH; Kenney D; Conway HL; Ewoldt JK; Chitalia VC; Crossland NA; Chen CS; Kotton DN; Baker SC; Fuchs SY; Connor JH; Douam F; Emili A; Saeed M
J Virol; 2021 Sep; 95(19):e0086221. PubMed ID: 34260266
[TBL] [Abstract][Full Text] [Related]
11. Disentangling molecular mechanisms regulating sensitization of interferon alpha signal transduction.
Kok F; Rosenblatt M; Teusel M; Nizharadze T; Gonçalves Magalhães V; Dächert C; Maiwald T; Vlasov A; Wäsch M; Tyufekchieva S; Hoffmann K; Damm G; Seehofer D; Boettler T; Binder M; Timmer J; Schilling M; Klingmüller U
Mol Syst Biol; 2020 Jul; 16(7):e8955. PubMed ID: 32696599
[TBL] [Abstract][Full Text] [Related]
12. ISGF3 and STAT2/IRF9 Control Basal and IFN-Induced Transcription through Genome-Wide Binding of Phosphorylated and Unphosphorylated Complexes to Common ISRE-Containing ISGs.
Nowicka H; Sekrecka A; Blaszczyk K; Kluzek K; Chang CY; Wesoly J; Lee CK; Bluyssen HAR
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139463
[TBL] [Abstract][Full Text] [Related]
13. Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-alpha: relevance to hepatitis C.
Joshi-Barve S; Amancherla K; Patil M; Bhatnagar A; Mathews S; Gobejishvili L; Cave M; McClain C; Barve S
Free Radic Biol Med; 2009 Jul; 47(1):47-54. PubMed ID: 19345260
[TBL] [Abstract][Full Text] [Related]
14. Expression of an IRF-3 fusion protein and mouse estrogen receptor, inhibits hepatitis C viral replication in RIG-I-deficient Huh 7.5 cells.
Yao L; Yan X; Dong H; Nelson DR; Liu C; Li X
Virol J; 2011 Sep; 8():445. PubMed ID: 21936899
[TBL] [Abstract][Full Text] [Related]
15. Seneca Valley virus 3C
Song J; Guo Y; Wang D; Quan R; Wang J; Liu J
J Virol; 2023 Oct; 97(10):e0072723. PubMed ID: 37819133
[TBL] [Abstract][Full Text] [Related]
16. Chromatin dynamics of gene activation and repression in response to interferon alpha (IFN(alpha)) reveal new roles for phosphorylated and unphosphorylated forms of the transcription factor STAT2.
Testoni B; Völlenkle C; Guerrieri F; Gerbal-Chaloin S; Blandino G; Levrero M
J Biol Chem; 2011 Jun; 286(23):20217-27. PubMed ID: 21498520
[TBL] [Abstract][Full Text] [Related]
17. The dynamic changes of interferon lambdas related genes and proteins in JAK/STAT pathway in both acute and chronic HIV-1 infected patients.
Zhao G; Liu L; Su B; Zhang T; Chen P; Li W; Wu H
AIDS Res Ther; 2017 Jun; 14(1):31. PubMed ID: 28623917
[TBL] [Abstract][Full Text] [Related]
18. UMP-CMP kinase 2 inhibits ZIKV replication through activation of type I IFN signaling pathway.
Zhu Y; Tan Q; Shi Y; Li Q; Li S; Wen W; Xie H; Li B; Duan X; Chen L
J Med Virol; 2024 Mar; 96(3):e29533. PubMed ID: 38483048
[TBL] [Abstract][Full Text] [Related]
19. HIV blocks Type I IFN signaling through disruption of STAT1 phosphorylation.
Nguyen NV; Tran JT; Sanchez DJ
Innate Immun; 2018 Nov; 24(8):490-500. PubMed ID: 30282499
[TBL] [Abstract][Full Text] [Related]
20. STAT2 is a primary target for measles virus V protein-mediated alpha/beta interferon signaling inhibition.
Ramachandran A; Parisien JP; Horvath CM
J Virol; 2008 Sep; 82(17):8330-8. PubMed ID: 18579593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
